{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:59:00Z","timestamp":1790805540653,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104419","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:52:44Z","timestamp":1784044364000},"page":"104419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["From barriers to cloud-based regulatory collaboration: An industry perspective on accelerating innovation in pharmaceutical manufacturing"],"prefix":"10.1016","volume":"115","author":[{"given":"Nina S.","family":"Cauchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marquerita","family":"Algorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-6647","authenticated-orcid":false,"given":"Kabir","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Griswold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Pawbake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104419_bib0002","article-title":"ISPE global pharmaceutical innovation survey findings: a review","author":"Potter","year":"2024","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0003","article-title":"An evaluation of postapproval CMC change timelines","author":"Harris","year":"2023","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0004","series-title":"Issues and challenges in access to medicines faced by small countries in the WHO European Region: policy brief","year":"2023"},{"key":"10.1016\/j.xphs.2026.104419_bib0005","first-page":"1","article-title":"Continuous manufacturing based paradigm shift in pharmaceuticals production and current regulatory framework","volume":"215","author":"Kardile","year":"2025","journal-title":"Chem Eng Res Des"},{"key":"10.1016\/j.xphs.2026.104419_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102828","article-title":"Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing","volume":"78","author":"Matanguihan","year":"2022","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.xphs.2026.104419_bib0007","doi-asserted-by":"crossref","first-page":"e3378","DOI":"10.1002\/btpr.3378","article-title":"Current challenges and recent advances on the path towards continuous biomanufacturing","volume":"39","author":"Drobnjakovic","year":"2023","journal-title":"Biotechnol Prog"},{"issue":"9","key":"10.1016\/j.xphs.2026.104419_bib0008","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1039\/D4DD00127C","article-title":"Bioprocessing 4.0: a pragmatic review and future perspectives","volume":"3","author":"Isoko","year":"2024","journal-title":"Digit Discov"},{"issue":"3","key":"10.1016\/j.xphs.2026.104419_bib0009","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.xphs.2021.08.032","article-title":"Re-envisioning pharmaceutical manufacturing: Increasing agility for global patient access","volume":"111","author":"Algorri","year":"2022","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2026.104419_bib0010","first-page":"28","article-title":"Nurturing manufacturing agility","volume":"46","author":"Fisher","year":"2022","journal-title":"Pharmaceutical Technology"},{"key":"10.1016\/j.xphs.2026.104419_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115504","article-title":"3D printing of pharmaceutical dosage forms: Recent advances and applications","volume":"217","author":"Auel","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104419_bib0012","unstructured":"International Society for Pharmaceutical Engineering. Pharma 4.0\u2122. Available at: https:\/\/ispe.org\/initiatives\/pharma-4.0. Accessed April 15, 2026."},{"issue":"2","key":"10.1016\/j.xphs.2026.104419_bib0013","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.xphs.2024.12.025","article-title":"Advancing the implementation of innovative analytical technologies in pharmaceutical manufacturing\u2014Some regulatory considerations","volume":"114","author":"Wang","year":"2025","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104419_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103914","article-title":"Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices","volume":"114","author":"Ghosh","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104419_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41378-024-00663-y","article-title":"A wearable, rapidly manufacturable, stability-enhancing microneedle patch for closed-loop diabetes management","volume":"10","author":"Liu","year":"2024","journal-title":"Microsyst Nanoeng"},{"issue":"8042","key":"10.1016\/j.xphs.2026.104419_bib0016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-024-08202-5","article-title":"Cephalopod-inspired jetting devices for gastrointestinal drug delivery","volume":"636","author":"Arrick","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2026.104419_bib0017","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41586-026-10221-3","article-title":"Towards intelligent and miniaturized drug delivery devices","volume":"651","author":"Wei","year":"2026","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.xphs.2026.104419_bib0018","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/molecules31030419","article-title":"The pharmaceutical industry in 2025: an analysis of FDA drug approvals from the perspective of Molecules","volume":"31","author":"de la Torre","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2026.104419_bib0019","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics","volume":"24","author":"Wang","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.xphs.2026.104419_bib0020","article-title":"Advancements in clinical RNA therapeutics: present developments and prospective outlooks","volume":"5","author":"Saw","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.xphs.2026.104419_bib0021","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","article-title":"The present and future of bispecific antibodies for cancer therapy","volume":"23","author":"Klein","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xphs.2026.104419_bib0022","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.xphs.2026.104419_bib0023","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.xphs.2026.104419_bib0024","unstructured":"CASSS. CMC Strategy Forum North America Summer 2025 scientific program. Available at: https:\/\/www.casss.org\/docs\/default-source\/cmc-strategy-forum-north-america\/final-programs\/cmc-strategy-forum-north-america-2025-summer-scientific-program.pdf?sfvrsn=270cc14d_5. Accessed April 9, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0025","author":"Yeung"},{"key":"10.1016\/j.xphs.2026.104419_bib0026","author":"Kovacs"},{"key":"10.1016\/j.xphs.2026.104419_bib0027","author":"Liu"},{"key":"10.1016\/j.xphs.2026.104419_bib0028","unstructured":"CASSS. CMC Strategy Forum North America Winter 2026 scientific program. Available at:https:\/\/www.casss.org\/docs\/default-source\/cmc-strategy-forum-north-america\/final-programs\/cmc-strategy-forum-north-america-winter-2026-scientific-program.pdf?sfvrsn=25e549a1_3. Accessed April 9, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0029","author":"Swisher"},{"issue":"3","key":"10.1016\/j.xphs.2026.104419_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/acsmedchemlett.9b00582","article-title":"New chemical modalities and strategic thinking in early drug discovery","volume":"11","author":"Blanco","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"12","key":"10.1016\/j.xphs.2026.104419_bib0031","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1016\/j.xphs.2020.09.025","article-title":"The confluence of innovation in therapeutics and regulation: recent CMC considerations","volume":"109","author":"Gutierrez","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104419_bib0032","article-title":"Toward a single global control strategy: industry study","author":"Beierle","year":"2022","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0033","series-title":"Successes and challenges in biomanufacturing: proceedings of a workshop-in brief","year":"2023"},{"key":"10.1016\/j.xphs.2026.104419_bib0034","article-title":"Barriers to innovation in pharmaceutical manufacturing: insights from five case studies","author":"Nosal","year":"2025","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0040","unstructured":"Directorate-General for Health and Food Safety. Annex 22: Artificial Intelligence. Draft guideline. Available at:https:\/\/health.ec.europa.eu\/document\/download\/5f38a92d-bb8e-4264-8898-ea076e926db6_en?filename=mp_vol4_chap4_annex22_consultation_guideline_en.pdf. Accessed April 17, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0042","unstructured":"U.S. Food and Drug Administration. Emerging Technology Program (ETP). Available at: https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/emerging-technology-program-etp. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0043","unstructured":"U.S. Food and Drug Administration. CDER\u2019s Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) Initiative. Available at:https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/cders-framework-regulatory-advanced-manufacturing-evaluation-frame-initiative. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0044","unstructured":"U.S. Food and Drug Administration. CBER Advanced Technologies Team (CATT). Available at: https:\/\/www.fda.gov\/vaccines-blood-biologics\/industry-biologics\/cber-advanced-technologies-team-catt. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0046","article-title":"Considerations for FDA\u2019s New Advanced Pharmaceutical Manufacturing Programs","author":"Colvill","year":"2024","journal-title":"Issue brief"},{"key":"10.1016\/j.xphs.2026.104419_bib0047","unstructured":"European Medicines Agency. Innovation Task Force briefing meetings. Available at:https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/innovation-task-force-briefing-meetings. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0049","unstructured":"European Medicines Agency. Opening procedures at EMA to non-EU authorities (OPEN) framework. Available at:https:\/\/www.ema.europa.eu\/en\/partners-networks\/international-activities\/multilateral-coalitions-initiatives\/opening-procedures-ema-non-eu-authorities-open-framework. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0050","unstructured":"Medicines and Healthcare products Regulatory Agency. MHRA Innovation Office. Available at: https:\/\/www.gov.uk\/government\/groups\/mhra-innovation-office. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0052","unstructured":"Health Products Regulatory Authority. Innovation Office. Available at:https:\/\/www.hpra.ie\/regulation\/classification-and-innovation-services\/hpra-innovation-office. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0053","unstructured":"Federal Agency for Medicines and Health Products (FAMHP). National Innovation Office. Available at: https:\/\/www.famhp.be\/en\/innovationoffice. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0054","unstructured":"Finnish Medicines Agency (Fimea). Support and advice for drug development. Available at: https:\/\/fimea.fi\/en\/marketing_authorisations\/support_and_advice_for_drug_development. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0055","unstructured":"Swissmedic. Swissmedic Innovation Office. Available at: https:\/\/www.innovation-office.ch\/. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0056","unstructured":"Health Sciences Authority. Innovation Office (Therapeutic Products and Cell, Tissue and Gene Therapy Products). Available at: https:\/\/www.hsa.gov.sg\/clinical-trials\/innovation-office. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0057","unstructured":"Health Sciences Authority. Innovation Office (Medical Devices). Available at: https:\/\/www.hsa.gov.sg\/medical-devices\/io. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0059","unstructured":"International Coalition of Medicines Regulatory Authorities. International Coalition of Medicines Regulatory Authorities (ICMRA). Available at: https:\/\/www.icmra.info\/drupal\/en\/home. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0061","unstructured":"World Health Organization. Collaborative Registration Procedure for medical products. Available at:https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/facilitated-product-introduction\/collaborative-registration-procedure. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0062","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH PQKM Task Force. Available at: https:\/\/www.ich.org\/page\/ich-pqkm-task-force. Accessed April 11, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0063","article-title":"Innovation and regulatory harmonization in Latin America: report on an ISPE workshop","author":"Winfield","year":"2025","journal-title":"Pharmaceutical Engineering iSpeak Blog"},{"key":"10.1016\/j.xphs.2026.104419_bib0065","series-title":"Regulatory Harmonization Steering Committee Meeting","article-title":"Advanced therapies and biotherapeutics priority work area champion update","year":"2026"},{"issue":"4","key":"10.1016\/j.xphs.2026.104419_bib0066","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s43441-021-00285-w","article-title":"Measuring progress of regulatory convergence and cooperation among Asia-Pacific Economic Cooperation (APEC) member economies in the context of the COVID-19 pandemic","volume":"55","author":"Chong","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.xphs.2026.104419_bib0068","series-title":"Second Regulatory Harmonization Steering Committee Meeting","article-title":"Regulatory Harmonization Steering Committee (RHSC) key performance indicators (KPIs) infographic for consideration","year":"2025"},{"issue":"1","key":"10.1016\/j.xphs.2026.104419_bib0069","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41120-023-00077-6","article-title":"Structured content and data management-enhancing acceleration in drug development through efficiency in data exchange","volume":"9","author":"Beierle","year":"2023","journal-title":"AAPS Open"},{"issue":"4","key":"10.1016\/j.xphs.2026.104419_bib0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5731\/pdajpst.2023.012850","article-title":"Worldwide regulatory reliance: Launching a pilot on a chemistry, manufacturing, and control post approval change for a vaccine","volume":"78","author":"Gastineau","year":"2024","journal-title":"PDA J Pharm Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104419_bib0071","first-page":"295","article-title":"Worldwide regulatory reliance: Results of an executed chemistry, manufacturing, and control post-approval change pilot","volume":"79","author":"Ban","year":"2025","journal-title":"PDA J Pharm Sci Technol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104419_bib0072","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s43441-024-00677-8","article-title":"Unleashing the power of reliance for post-approval changes: A journey with 48 national regulatory authorities","volume":"58","author":"Mangia","year":"2024","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.xphs.2026.104419_bib0075","unstructured":"European Medicines Agency. Reliance for post-authorisation changes: pilots for the pharmaceutical industry. Available at: https:\/\/www.ema.europa.eu\/en\/partners-networks\/international-activities\/multilateral-coalitions-initiatives\/reliance-applied-post-autorisation-changes-pilots-pharmaceutical-industry Accessed April 13, 2026."},{"issue":"4","key":"10.1016\/j.xphs.2026.104419_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104193","article-title":"Pioneering the future: Delivering the first digitally generated CMC post-approval change (PAC) dossier to global regulators simultaneously","volume":"115","author":"Algorri","year":"2026","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104419_bib0078","author":"Ban"},{"key":"10.1016\/j.xphs.2026.104419_bib0079","article-title":"A cohesive vision for a single global CMC dossier","author":"Algorri","year":"2026","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0080","article-title":"Streamlining postapproval submissions using ICH Q12 & SCDM","author":"Gavin","year":"2022","journal-title":"Pharmaceutical Engineering"},{"key":"10.1016\/j.xphs.2026.104419_bib0081","unstructured":"GDPR.eu. Complete guide to GDPR compliance. Available at: https:\/\/gdpr.eu\/. Accessed June 23, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0084","unstructured":"Law n. 13,709\/2018 - Provides for the protection of personal data and changes Law n. 12,965\/2014 (Brazilian Civil Rights Framework for the Internet). Available at: https:\/\/www.lgpdbrasil.com.br\/wp-content\/uploads\/2019\/06\/LGPD-english-version.pdf. Accessed June 24, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0085","unstructured":"The Organisation for Professionals in Regulatory Affairs (TOPRA). Digital transformation of global regulatory affairs: then, now and next. Regulatory Rapporteur. Available at: https:\/\/www.regulatoryrapporteur.org\/product-information\/digital-transformation-of-global-regulatory-affairs-then-now-and-next\/946.article. Accessed June 24, 2026."},{"key":"10.1016\/j.xphs.2026.104419_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123342","article-title":"Real-time algorithmic exchange and processing of pharmaceutical quality data and information","volume":"645","author":"Anderson","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104419_bib0087","author":"Ritchie"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:24:39Z","timestamp":1790803479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926002686"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104419","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From barriers to cloud-based regulatory collaboration: An industry perspective on accelerating innovation in pharmaceutical manufacturing","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104419"}}